Annex 3 Sample Clauses

Annex 3. IAC may enforce the provisions of Annex 3, so long as IAC remains a shareholder of eLong.
AutoNDA by SimpleDocs
Annex 3. Example of an arrangement of the approval xxxx
Annex 3. If the Patents marked with either a B1 or B2 restriction are [**] prevails in the [**] and [**] for such Patents broadly cover [**], the licenses under such Patents are limited to discover, develop, make, have made, use, sell, have sold, offer to sell, import and have imported Antisense Products and to practice Antisense Technology; provided that the license will only extend to the issued claims corresponding to the [**] and shall not extend to any other claim of such Patents. The licenses under the Patents marked with an F restriction are limited (i) to discover, develop, make, have made, use, sell, have sold, offer to sell, import and have imported Antisense Products which contain modifications which have [**], (ii) to practice Antisense Technology using oligonucleotides [**] in such oligonucleotides, and (iii) to discover, develop, make, have made, use, sell, have sold, offer to sell, import and have imported Antisense Products which target genes involved in [**]. The licenses under the Patents marked with a C or D restriction are limited to discover, develop, make, have made, use, sell, have sold, offer to sell, import and have imported Antisense Products and practice Antisense Technology, provided that neither such Antisense Products nor such Antisense Technology use, or are used with, [**]. The licenses under the Patents marked with an A restriction are limited to discover, develop, make, have made, use, sell, have sold, offer to sell, import and have imported Antisense Products and practice Antisense Technology, provided that such Antisense Products and Antisense Technology use, or are used with, the technology covered by the claims of such Patents solely for the [**] purposes only. The licenses under the Patents marked with an M restriction are limited to discover, develop, make, have made, use, sell, have sold, offer to sell, import and have imported Antisense Products and practice Antisense Technology, which Antisense Products and Antisense Technology primarily act [**]. The licenses under the Patents marked with a K restriction are limited to discover, develop, make, have made, use, sell, have sold, offer to sell, import and have imported Antisense Products and practice Antisense Technology; provided, however, that such licenses will not extend to [**]. For purposes of this description:
Annex 3Addendum to the communication concerning a type of retrofit emission control device (REC) pursuant to Regulation No. 132
Annex 3. 04.1 includes a complete and detailed picture of EFT Estimated Working Capital corresponding to 2016. The sum of the following accounts: (i) Target Financial Debt and (ii) Target Debt Equivalents will be the financial debt of the transaction (“Target Financial Debt of the Transaction”).
Annex 3. 04.6 includes an example of the EFT Promissory Seller Closing Price as at May 31, 2017, with reference values.
Annex 3. 2, Training and Courses is cancelled in its entirety and replaced by a new Annex 3.2, Training and Courses, Revision 2.0 which is attached to this Amendment no. 2 as Annex 11.
AutoNDA by SimpleDocs
Annex 3. Essential characteristics of the vehicle powered by a hybrid electric power train and information concerning the conduct of tests
Annex 3. SUPPLIER'S STATEMENT FOR NON-ORIGINATING MATERIALS USED IN THE PRODUCTION OF NON-ORIGINATING PRODUCTS (a) The following materials which do not originate in the European Union/in Canada(1) have been used in the European Union/in Canada to produce the following supplied non-originating products. (b) Any other materials used in the European Union/in Canada to produce these products originate there. 1 Description of non-originatin g product(s) supplied 2 HS tariff classification of non-originatin g product(s) supplied 3 Value of non-originatin g product(s) supplied(2) 4 Description of non-originatin g material(s) used 5 HS tariff classification of non-originatin g material(s) used 6 Value of non-originatin g materials used(2) Total: Total: I undertake to make available any further supporting documents required. ………………………………………………………………………………………………………………………… ………………………………………………………………………………………………………………………… (Name and position, name and address of company) ………………………………………………………………………………………………………………………… (1) Strikethrough the Party not applicable, as the case may be. (2) For each non-originating product supplied and non-originating material used, specify the value per unit of the products and materials described in columns 3 and 6, respectively.
Annex 3. (A) contains the balance sheet of CaixaBank, and Annex 3.(B) the balance sheet of Banca Cívica. The balance sheets of CaixaBank and Banca Cívica, checked by their respective external auditors, will be submitted to the approval of the Annual General Meeting of Shareholders of CaixaBank, scheduled for 19 April 2012, and the Annual General Meeting of Shareholders of Banca Cívica, scheduled for 23 May 2012.
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!